Schroll Medical ApS
Credit rating
Company information
About Schroll Medical ApS
Schroll Medical ApS (CVR number: 39467135) is a company from FAABORG-MIDTFYN. The company recorded a gross profit of 30.4 mDKK in 2023. The operating profit was 3208.9 kDKK, while net earnings were 2442.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 3.6 %, which can be considered weak and Return on Equity (ROE) was 3.5 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 81.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Schroll Medical ApS's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | - 102.51 | -31.37 | 10 713.33 | 20 124.15 | 30 413.59 |
EBIT | - 102.51 | -3 031.37 | -8 045.88 | -4 331.36 | 3 208.90 |
Net earnings | - 147.76 | -2 022.47 | -5 230.80 | -3 108.27 | 2 442.48 |
Shareholders equity total | 19 852.24 | 27 829.78 | 52 598.98 | 69 490.71 | 71 933.18 |
Balance sheet total (assets) | 32 389.92 | 46 981.18 | 71 596.07 | 89 746.87 | 88 166.71 |
Net debt | 8 342.26 | 11 652.86 | 4 920.91 | 5 805.12 | - 247.26 |
Profitability | |||||
EBIT-% | |||||
ROA | -0.3 % | -7.6 % | -13.6 % | -5.4 % | 3.6 % |
ROE | -0.7 % | -8.5 % | -13.0 % | -5.1 % | 3.5 % |
ROI | -0.3 % | -8.0 % | -14.4 % | -5.7 % | 3.9 % |
Economic value added (EVA) | -66.63 | -2 322.95 | -5 666.74 | -4 216.04 | 374.70 |
Solvency | |||||
Equity ratio | 61.3 % | 59.2 % | 73.5 % | 77.4 % | 81.6 % |
Gearing | 42.0 % | 42.1 % | 10.5 % | 8.4 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.4 | 0.5 | 1.2 | 1.2 | 1.3 |
Current ratio | 0.4 | 1.8 | 3.3 | 4.8 | 8.3 |
Cash and cash equivalents | 61.61 | 580.05 | 5.45 | 247.26 | |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BB | BBB | A | AA |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.